Bio Protocol vs DigiByte — how do they compare? Bio Protocol trades at Rp430.78 (market cap Rp974,32M, Rp147,16M 24h volume), while DigiByte trades at Rp72.51 (market cap Rp1,33T, Rp43,67M 24h volume). The key difference: DigiByte is far larger — about 1365.1× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 18,4B / 21B DGB (88%) for DigiByte. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and DigiByte for 22 Days on average.
| BIO | DGB | |
|---|---|---|
Market Cap | Rp974,32M | Rp1,33T |
Volume (24h) | Rp147,16M | Rp43,67M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 18,4B / 21B DGB (88%) |
Typical Hold Time | 18 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
DigiByte is trading at Rp73.499 with a market cap of Rp1.35T, showing bullish technical signals with strong moving average support and key indicators favoring buying activity. The asset maintains 88% circulation rate with support levels at Rp69-72 and resistance at Rp75-78. Recent technical momentum suggests upward potential despite neutral RSI readings.
Overall outlook remains positive with strong technical momentum, though investors should monitor resistance levels and cryptocurrency market volatility. Key opportunities include potential breakout above resistance, while risks involve typical crypto volatility and regulatory uncertainties affecting the broader digital asset space.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →DigiByte (DGB) is an open-source blockchain and asset creation platform. Its development started in October 2013, and its genesis block was mined in January 2014 as a fork of Bitcoin (BTC).
Read more on DGB →